ClinConnect ClinConnect Logo
Search / Trial NCT02230826

Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty

Launched by CORIN · Sep 2, 2014

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Arthroplasty Hip Replacement Acetabular Cup Femoral Stem

ClinConnect Summary

This clinical trial is an observational study looking at the long-term outcomes of hip replacement surgeries using specific hip devices made by Corin. The goal is to gather important information about how safe and effective these devices are for patients over time. If you or a family member are considering hip replacement surgery, this study could provide valuable insights into what to expect in the years following the procedure.

To participate, individuals must be at least 18 years old and have been advised to undergo hip replacement surgery using Corin devices. However, people with certain health conditions, such as serious tumors or high surgical risks, may not be eligible. Participants in this study will be asked to agree to take part and will need to follow up on their health after surgery. This study is currently recruiting participants of all genders, and it's designed to help improve future hip replacement surgeries for everyone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Man or woman \>18 years
  • Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
  • Subjects who agreed for study participation.
  • Exclusion Criteria:
  • Subjects with existing tumour and/or particularly high surgical risk-
  • Subjects with anaesthetic risk class IV or higher
  • Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
  • Contraindications for arthroplasty with a Corin hip devices as per product IFU

About Corin

Corin is a leading medical technology company specializing in the development of innovative solutions for the management of cardiovascular diseases. With a strong focus on improving patient outcomes, Corin leverages advanced data analytics and cutting-edge technology to enhance the precision and effectiveness of cardiac care. The company's commitment to research and development drives its clinical trials, aimed at validating and optimizing its products, ensuring they meet the highest standards of safety and efficacy. Through collaboration with healthcare professionals and institutions, Corin strives to advance the field of cardiology and provide healthcare providers with the tools they need to deliver exceptional patient care.

Locations

Nice, , France

Dunkerque, , France

Bordeaux, , France

Cannes, , France

Hénin Beaumont, , France

Orléans, , France

Paris, , France

Paris, , France

Pessac, , France

Roubaix, , France

St Georges De Didonne, , France

Toulouse, , France

Valenciennes, , France

Patients applied

0 patients applied

Trial Officials

Goulven Rochcongar, MD

Study Chair

University Hospital, Caen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials